ABEC , a leading global provider of biomanufacturing engineering solutions and services, announced today that it will supply custom large-scale, large-scale products to EKF Life Sciences , a division of EKF Diagnostics Holdings plc Bioprocessing equipment including a stainless steel fermenter with a total volume of 14,500 liters and an 8,000 liter media preparation system. EKF Life Sciences produces diagnostic enzymes and contract custom products for use in the medical diagnostic, pharmaceutical and industrial industries. The agreement will provide bioprocessing equipment at EKF Life Sciences' South Bend, Indiana facility, which will significantly increase EKF's production capacity for enzymes used in a variety of diagnostic and life science applications.

As an industry leader in high-quality diagnostic materials, EKF is committed to delivering timely and cost-effective critical products to the global life sciences and healthcare industries. ABEC has over 45 years of experience designing large fermenters and full in-house engineering and manufacturing capabilities. ABEC will provide engineering services for EKF's new fermentation facility to ensure optimal process performance and seamless integration of the facility. The 14,500-liter fermenter will feature ABEC's patented internal cooling baffles that support efficient cleaning, optimal heat removal and maximum fermenter productivity.

Mike Salter, CEO of EKF Diagnostics Holdings plc, said : "EKF Life Sciences is committed to developing new products and capabilities to best serve the in vitro diagnostics market on a global scale. This partnership with ABEC is another step in accelerating our organic growth strategy. An important step. Their innovative equipment and resources will allow us to rapidly address specific manufacturing requirements, and we look forward to working with them as we continue to expand our biomanufacturing capabilities and capacity."

ABEC CEO and Chairman Scott Pickering said: "ABEC's innovative technology and complete turnkey solutions are unique in the industry. We look forward to continuing to support EKF's expansion and growth."

About ABEC

ABEC has been a leader in providing process solutions and services to the global biopharmaceutical industry since 1974. Most of the world's pharmaceutical and biotechnology companies are ABEC customers; many of today's mainstream medicines are produced on process equipment that ABEC designs, manufactures, installs, and services. ABEC's unique value comes from years of experience, complete in-house capabilities, a flexible approach to customization, and long-term credibility. Whether by adding capacity or improving existing facilities, ABEC's total solutions and support services can reduce overall costs and time-to-market while helping to unlock full production potential. To learn more about ABEC, visit abec.com , or email info@abec.com .

About EKF Life Sciences

Since 1983, EKF Life Sciences has been producing bacterial fermentation enzymes and related biomolecules for in vitro diagnostics. Since then, it has formed a core competency in technology transfer to commercialization and scaled up the fermentation process from benchtop vessels to mass production of stable and reliable enzymes. These stably mass-produced enzymes are used for mass production of test kits.

With the continued development of microbial expression platforms and the growing interest in medical and industrial applications for biomanufacturing intermediates and products, EKF Life Sciences plays an important role in the evolution of improved, environmentally sensitive manufacturing processes. one ring.

Disclaimer: The original version of this announcement is the official authorized version. The translation is for convenience only. Please refer to the original text. The original version is the only legally binding version.

Contacts
Media Contact:
Susan Cooper Curcio,  

+1 (610) 861 4666

scurcio@abec.com 

Walbrook PR Limited
Paul McManus / Lianne Applegarth
Tel: +44 (0)20 7933 8780

ekf@walbrookpr.com
Mobile: +44 (0)7980 541 893 / +44 (0)7584 391 303

 

Source:businesswire.com

Report Abuse